131+ Sleep Apnea Statistics You Should Know in 2026

If you want to understand the scope, risks, and treatment of sleep apnea, I’ve compiled this list for you.

I was diagnosed with severe obstructive sleep apnea more than a decade ago with an AHI of 51. Since then, I’ve followed the research closely. Below are 131 sleep apnea statistics drawn from peer-reviewed studies and established clinical organizations. I’m not a doctor — my background is in computer science — so where I couldn’t trace a number to a reliable source, I left it out.

Global Prevalence

1. An estimated 936 million adults aged 30–69 worldwide have mild to severe obstructive sleep apnea (Benjafield et al., Lancet Respiratory Medicine, 2019).
2. Approximately 425 million of those adults have moderate to severe OSA.
3. OSA prevalence exceeded 50% in some countries in the Lancet analysis.
4. China has the highest number of people with OSA globally, followed by the United States, Brazil, and India.
5. Nearly 30 million Americans have obstructive sleep apnea (AASM).
6. More than 80% of moderate to severe OSA cases in the U.S. remain undiagnosed (AASM).
7. Up to 30% of men in the U.S. meet the diagnostic criteria for OSA.
8. Up to 17% of women in the U.S. meet the diagnostic criteria for OSA.
9. OSA is the most common sleep-related breathing disorder.
10. A 2025 modeling study projected 76.6 million U.S. adults aged 30–69 will have OSA by 2050.

Demographics and Risk Factors

11. Men are diagnosed with OSA at roughly twice the rate of women before age 50.
12. After menopause, women’s OSA risk approaches that of men.
13. Women are disproportionately underdiagnosed, often presenting with insomnia and fatigue rather than snoring.
14. Rates of undiagnosed OSA are higher among women, racial and ethnic minorities, and people in low-income or rural communities (AASM).
15. Obesity is involved in approximately 60% of moderate to severe OSA cases.
16. In obese children, OSA prevalence rises to approximately 60%.
17. Neck circumference over 17 inches in men is an established risk factor.
18. A waistline over 40 inches is associated with significantly elevated OSA risk.
19. A family history of OSA raises individual risk.
20. Alcohol consumption before bed worsens airway muscle relaxation and increases apnea severity.
21. Smoking is associated with increased OSA risk.
22. Chronic nasal congestion contributes to OSA by increasing mouth breathing.
23. Asthma sufferers have a higher rate of OSA than the general population.
24. PCOS increases the likelihood of OSA in women.
25. Low thyroid hormone levels are associated with increased OSA risk.
26. Hormonal changes during menopause increase susceptibility to OSA.
27. Supine (back) sleeping worsens OSA in many patients.
28. Sedative medications increase upper airway muscle relaxation and can worsen OSA.

Pediatric Sleep Apnea

29. OSA affects an estimated 1–5% of children.
30. Peak incidence in children occurs in preschool age, when tonsil hypertrophy is most prevalent.
31. Adenotonsillar hypertrophy is the leading cause of pediatric OSA.
32. Adenotonsillectomy is the most common first-line surgical treatment for pediatric OSA.
33. Children with Down syndrome are at significantly elevated risk for OSA.
34. Obese children with OSA have a moderate to severe disease rate of approximately 71%.
35. Up to 30% of children with OSA also have ADHD.
36. Pediatric OSA is associated with behavioral problems, learning difficulties, and impaired growth.
37. Allergic rhinitis and adenoid hypertrophy frequently co-occur with pediatric OSA.
38. Diagnosis of OSA in children is often delayed due to limited sleep testing resources.

Health Consequences of Untreated OSA

39. Severe OSA is associated with roughly double the hazard for all-cause mortality (meta-analysis, PMC3723897).
40. Cardiovascular mortality risk is approximately 2.65 times higher in people with severe OSA (meta-analysis, PMC3723897).
41. OSA is associated with an odds ratio of 2.24 for incident stroke (pooled analysis, AHA Journals).
42. 40–80% of people with cardiovascular disease also have OSA.
43. 83% of people with treatment-resistant hypertension have OSA.
44. 50% of people with atrial fibrillation have been found to have undiagnosed OSA.
45. 70% of stroke survivors have some form of sleep-disordered breathing.
46. OSA approximately triples the risk of motor vehicle accidents due to impaired alertness.
47. An estimated 45% of people with type 2 diabetes also have OSA.
48. Depression and anxiety are significantly more common in people with untreated OSA.
49. Cognitive impairment, memory problems, and brain fog are frequently reported in untreated OSA.
50. OSA is linked to increased dementia risk in older adults.
51. Chronic morning headaches are a recognized symptom of OSA, caused by CO2 buildup and sleep fragmentation.
52. GERD symptoms are more common in people with untreated OSA and often improve with CPAP therapy.
53. OSA is associated with reduced quality of life across multiple dimensions including daytime function and mood.
54. Intermittent hypoxia from OSA has downstream effects on cardiovascular, metabolic, and neurological health.
55. Nighttime urination (nocturia) is a commonly reported symptom of OSA.
56. OSA is associated with reduced testosterone levels in men.
57. Sexual dysfunction including erectile dysfunction is more common in men with untreated OSA.
58. Snoring occurs in the vast majority of OSA cases, though not all snorers have OSA.

Diagnosis and Testing

59. Polysomnography (in-lab sleep study) remains the gold standard for OSA diagnosis.
60. The Apnea-Hypopnea Index (AHI) is used to classify OSA severity: mild (5–14 events/hour), moderate (15–29), severe (30+).
61. Home sleep apnea tests (HSAT) can reliably diagnose moderate to severe OSA in people with a high pre-test probability.
62. Misdiagnosis is common, especially in women whose symptoms differ from the textbook presentation.
63. Many people go undiagnosed for years, with symptoms attributed to stress, aging, or other conditions.
64. The Epworth Sleepiness Scale is a widely used tool for quantifying daytime sleepiness.
65. The STOP-BANG questionnaire is used in clinical settings to screen for OSA risk.
66. General public awareness of sleep apnea remains low.
67. Polysomnography is resource-intensive and unavailable in many parts of the world, which drives underdiagnosis.
68. Home sleep testing technology has improved substantially, increasing diagnostic access.
69. Sleep apnea screening is recommended before surgery due to elevated anesthesia risk in people with OSA.
70. Wearable ring-based pulse oximeters are increasingly used to monitor nocturnal oxygen levels.

CPAP Therapy

71. CPAP is the first-line recommended treatment for moderate to severe OSA (AASM guidelines).
72. CPAP adherence is typically defined as four or more hours of use per night on at least 70% of nights.
73. Real-world CPAP adherence rates typically range from 30–60% in published studies.
74. Close to half of new CPAP users discontinue therapy within the first year.
75. Mask discomfort and claustrophobia are among the most common reasons for early CPAP abandonment.
76. Full face masks are recommended for chronic mouth breathers.
77. Heated humidification reduces nasal dryness and improves comfort, which supports long-term adherence.
78. Consistent CPAP use is associated with reduced blood pressure in people with hypertension and OSA.
79. Long-term CPAP use is associated with reduced stroke risk.
80. CPAP reduces AHI to below 5 events per hour in most users when used correctly.
81. CPAP eliminates snoring in most users.
82. Daytime alertness and energy typically improve within days to weeks of starting effective CPAP therapy.
83. CPAP therapy is associated with reductions in emergency department visits and hospitalizations.
84. Patient education and close follow-up in the first weeks of therapy significantly improve long-term adherence.
85. Telehealth monitoring via apps allows daily tracking of therapy data including AHI, mask leak, and hours of use.
86. CPAP machines typically last around five years.
87. Insurance in the U.S. often covers CPAP equipment and replacement supplies on a set schedule.
88. Auto-titrating CPAP (APAP) adjusts pressure breath-by-breath based on detected airway resistance.

Alternative Treatments

89. Oral appliances that reposition the lower jaw are effective in approximately 70–80% of mild to moderate OSA cases.
90. Positional therapy — avoiding back sleeping — benefits patients whose OSA is significantly worse in the supine position.
91. Weight loss is one of the most effective long-term interventions for OSA, particularly in obese patients.
92. Nasal EPAP devices offer a non-powered alternative for mild to moderate OSA.
93. Upper airway surgery including UPPP can reduce OSA severity but rarely eliminates it entirely.
94. Hypoglossal nerve stimulation (Inspire therapy) reduces AHI by approximately 68% in eligible patients who cannot tolerate CPAP.
95. Sleeping on the side rather than the back can meaningfully reduce apnea events in positional OSA.
96. Quitting smoking reduces airway inflammation and is associated with improved sleep-disordered breathing.
97. Avoiding alcohol within several hours of bedtime reduces apnea severity.

Innovation and Emerging Research

98. Tirzepatide (Zepbound) became the first weight-loss drug to receive FDA approval specifically for treating OSA in adults with obesity.
99. In clinical trials, Zepbound reduced sleep disruption events by over 60% in participants with OSA.
100. Apple Watch includes a sleep apnea notification feature using wrist motion data, though it is a screening indicator, not a diagnostic tool.
101. AI-based analysis tools are being developed to detect OSA from wearable sensor data with increasing accuracy.
102. ASV (adaptive servo-ventilation) therapy is used for central sleep apnea and complex sleep apnea not responsive to standard CPAP.
103. BiPAP therapy delivers different pressures on inhale and exhale and is used for patients who cannot tolerate the continuous pressure of CPAP.
104. Home sleep testing devices continue to improve in accuracy, increasing diagnostic access outside sleep labs.
105. Bluetooth-enabled CPAP machines allow remote monitoring by sleep clinicians, enabling earlier intervention when problems arise.
106. Research into pharmacological treatments for OSA beyond weight-loss drugs is ongoing, including drugs targeting upper airway muscle tone.

Economic Impact

107. The annual economic burden of undiagnosed OSA in the U.S. is approximately $149.6 billion (AASM / Frost and Sullivan, 2016).
108. Lost workplace productivity accounts for the largest share of that burden: $86.9 billion annually.
109. Motor vehicle accidents linked to OSA account for an estimated $26.2 billion annually.
110. Workplace accidents linked to OSA account for an estimated $6.5 billion annually.
111. Increased healthcare utilization from OSA-related comorbidities adds an estimated $30 billion annually.
112. Consistent CPAP treatment has been shown to reduce overall healthcare spending over time.
113. Commercial truck drivers have elevated rates of OSA, with estimates suggesting 28% or more may be affected.
114. Treating OSA in the workplace setting is associated with reduced absenteeism and improved productivity.
115. The global market for sleep apnea devices continues to grow in line with rising prevalence rates.

Living with Sleep Apnea

116. Sleep apnea affects relationships: a partner’s snoring and restless sleep frequently disrupts their bed partner’s sleep as well.
117. Many people with OSA report significant improvements in mood, energy, and cognitive function within weeks of effective treatment.
118. Morning headaches that resolve after starting CPAP therapy are a commonly reported experience among new users.
119. People with OSA frequently underestimate their own daytime sleepiness because impaired alertness becomes their baseline.
120. Travel with CPAP is manageable: travel machines like the ResMed AirMini are designed for portability, and most airlines allow CPAP as a carry-on.
121. CPAP use is possible while camping, using battery packs or solar charging systems designed for PAP therapy.
122. Many CPAP users report that it takes several weeks to feel fully comfortable with the mask and machine.
123. Consistent daily CPAP cleaning — mask cushion, tubing, and humidifier — is recommended to prevent bacteria buildup and extend equipment life.
124. Distilled water is recommended for CPAP humidifiers to prevent mineral deposits and bacterial growth.
125. CPAP replacement schedules for masks, cushions, filters, and tubing are typically covered by insurance on a defined timeline.
126. People with untreated OSA have higher rates of workplace accidents and errors due to chronic sleep deprivation.
127. OSA is a lifelong condition for most people; there is no cure for the majority of cases, though symptoms can be effectively controlled.
128. Social stigma around CPAP use remains a barrier to adherence for some patients.
129. Peer support groups and online communities are frequently cited by CPAP users as helpful for troubleshooting and motivation.
130. Regular follow-up with a sleep clinician — not just initial setup — is associated with better long-term therapy outcomes.
131. People with severe untreated OSA have a measurably shorter life expectancy than those who receive and adhere to treatment.

Sources: Benjafield AV et al., Lancet Respiratory Medicine (2019), PMID 31300334 • American Academy of Sleep Medicine / Frost and Sullivan, “Hidden Health Crisis Costing America Billions” (2016) • aasm.org • Additional statistics sourced from peer-reviewed literature as noted inline.

⚠️ MEDICAL DISCLAIMER This blog provides general information only and is not a substitute for professional medical advice, diagnosis, or treatment. Sleep apnea is a serious condition, and CPAP equipment should be used under proper medical supervision. Always consult your doctor or sleep specialist before starting, stopping, or changing any therapy. I share personal experiences as a CPAP user, not as a medical professional. Individual results vary. For medical guidance, please consult a qualified clinician or the American Academy of Sleep Medicine (aasm.org).